PXN and breast cancer: We provide evidence that paxillin Tyr31 phosphorylation is involved in the migration and invasion of breast cancer cells, suggesting that paxillin Tyr31 phosphorylation could be a potential therapeutic target for mitigating breast cancer metastasis.